Source: Eur Respir Rev, 29 (155) 190147; 10.1183/16000617.0147-2019
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Franck F. Rahaghi, Nadera J. Sweiss, Lesley Ann Saketkoo, Mary Beth Scholand, Joseph B. Barney, Alicia K. Gerke, Elyse E. Lower, Mehdi Mirsaeidi, Lanier O'Hare, Mark J. Rumbak, Lobelia Samavati, Robert P. Baughman. Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study. Eur Respir Rev, 29 (155) 190147; 10.1183/16000617.0147-2019

Member's Comments

No comment yet.

Related content which might interest you: Algorithm for pulmonary hypertension screening in sarcoidosis: A Delphi Consensus Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Steroid treatment effect in pulmonary sarcoidosis (STEPS study) Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis Source: Eur Respir Rev, 29 (155) 190146; 10.1183/16000617.0146-2019 Year: 2020 Acute exacerbation of COPD patients therapy priorities: A survey study Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Subcutaneous treprostinil: a new therapeutic approach for idiopathic paediatric pulmonary hypertension Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019 Year: 2020 Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Subcutaneous sarcoidosis: A clinical analysis of nine patients Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Late Breaking Abstract - Development of a self-management package for pulmonary fibrosis: an international Delphi study Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Bronchoscopy-guided topical hemostatic tamponade therapy as the initial management for hemoptysis: a pilot study (Philippines) Source: Annual Congress 2008 - Trends in interventional pulmonology Year: 2008 How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study Source: International Congress 2014 – Sarcoidosis Year: 2014 Oral steroid intervention in severe asthma: focus on phenotypes. Report from the bioair study Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma Year: 2009 Established and experimental medical therapy of pulmonary sarcoidosis Source: Eur Respir J 2013; 41: 1424-1438 Year: 2013 Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Expectations of patients suffering from idiopathic pulmonary fibrosis about their treatment: results of the French national survey, RESPIR Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey Source: Eur Respir Rev 2014; 23:225-230 Year: 2014